ipilimumab
-
New mRNA Cancer Vaccine Passes Important Human Trial
In patients with advanced melanoma, the vaccine along with immunotherapy reduced the risk of cancer recurrence and death by 44%, the companies said.
The News Of Tomorrow, Today
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.
By subscribing you agree to our Terms of Use and Privacy Policy.